Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 5
2005 8
2006 8
2007 4
2008 6
2009 7
2010 7
2011 9
2012 10
2013 12
2014 11
2015 20
2016 24
2017 23
2018 36
2019 41
2020 38
2021 38
2022 52
2023 47
2024 70
2025 80
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

525 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial.
Chen L, Li H, Zhang H, Yang H, Qian J, Li Z, Ren Y, Wang S, Fu P, Yang H, Liu Y, Sun J, Nie J, Lei R, Yao Y, Zhang A, Wang S, Ma X, Ouyang Z, Yang H, Wu SY, Cao SW, Wang K, Jiang A, Ouyang Q, Pang D, Wei L, Zha X, Shen Y, Qu X, Wu F, Zhu X, Wang Z, Fan L, Shao ZM. Chen L, et al. Among authors: yang h. JAMA. 2025 Feb 25;333(8):673-681. doi: 10.1001/jama.2024.23560. JAMA. 2025. PMID: 39671272 Free PMC article. Clinical Trial.
Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Wu XK, Stener-Victorin E, Kuang HY, Ma HL, Gao JS, Xie LZ, Hou LH, Hu ZX, Shao XG, Ge J, Zhang JF, Xue HY, Xu XF, Liang RN, Ma HX, Yang HW, Li WL, Huang DM, Sun Y, Hao CF, Du SM, Yang ZW, Wang X, Yan Y, Chen XH, Fu P, Ding CF, Gao YQ, Zhou ZM, Wang CC, Wu TX, Liu JP, Ng EHY, Legro RS, Zhang H; PCOSAct Study Group. Wu XK, et al. JAMA. 2017 Jun 27;317(24):2502-2514. doi: 10.1001/jama.2017.7217. JAMA. 2017. PMID: 28655015 Free PMC article. Clinical Trial.
Poly[di-μ9-citrato-tetra-sodiumzinc].
Ma YH, Yang HW, Hao JT, Ma PZ, Yao T. Ma YH, et al. Acta Crystallogr Sect E Struct Rep Online. 2013 Nov 20;69(Pt 12):m672. doi: 10.1107/S1600536813030067. eCollection 2013 Nov 20. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 24454178 Free PMC article.
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yin Y, Zhang Q, Sun T, Hao C, Wang Z, Yang J, Wang Y, Shi Y, Sun J, Ouyang Q, Su H, Wu J, Gan L, Han M, Gao L, Wang X, Zhao B, Li H, Zhao J, Yang H, Ning F, Tian F, Zhang J, Sun H, Niu Z, Zong H, Zang A, Wang X, Qian X, Wu S, Nie J, He L, Cheng Y, Hao Y, Zhai Y, Li H, Wang J, Wei S, Li M, Liu Y, Guo H, Hu Q, Liu L, Han X, Luo R, Ni M, Tang X, Zhai Z, Ding M, Wang H, Shen P, Wang X, Liu L, Chen W, Liu G, Cai Z, Jiang Z. Yin Y, et al. Among authors: yang h. Signal Transduct Target Ther. 2025 Dec 18;10(1):414. doi: 10.1038/s41392-025-02475-6. Signal Transduct Target Ther. 2025. PMID: 41413016 Free PMC article. Clinical Trial.
An advanced furoxan-bridged heat-resistant explosive.
Li C, Zhu T, Tang J, Lei C, Yu G, Yang Y, Yang H, Xiao C, Cheng G. Li C, et al. Among authors: yang h. Mater Horiz. 2024 Nov 11;11(22):5701-5708. doi: 10.1039/d4mh00999a. Mater Horiz. 2024. PMID: 39233605
Triaqua-(1,10-phenanthroline-κN,N')(sulfato-κO)zinc(II).
Liu H, Qin H, Zhang YJ, Yang HW, Zhang J. Liu H, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 29;67(Pt 2):m280-1. doi: 10.1107/S1600536811003138. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21522926 Free PMC article.
525 results